Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics

Withdrawn before enrolling · Phase 2 · Has a placebo group

Conditions studied: Cocaine Dependence

In brief

No medications are currently available for treatment of psychostimulant addiction, a compulsive preoccupation with use of cocaine and related compounds. Tacrine, a medication that is currently prescribed for Alzheimer's disease, can decrease the amount of cocaine injections that laboratory animals choose to inject by vein. This project will determine if tacrine can also decrease cocaine-motivated behavior for human subjects in a laboratory setting.

Key facts

Study ID

NCT01406522

Run by

Midwest Biomedical Research

People needed

0

Starts

2012-10-01

Expected to finish

2013-11-01

Last updated by the study team

2013-12-18

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV-TR criteria for cocaine abuse or dependence, with at least one cocaine-positive urine specimen within the six weeks prior to enrollment.
• Has used cocaine for a duration of at least 6 months, with at least weekly use during the last 30 days by a rapid route of administration (either smoked or intravenous injection).
• Is male or female, between 21 and 50 years old.

You may not qualify if…

• Has a history of a medical adverse reaction to cocaine or other psychostimulants, including loss of consciousness, chest pain, cardiac ischemia, or seizure.
• Has any current Axis I psychiatric disorder other than drug abuse or dependence.
• Meets DSM-IV-TR criteria for dependence on opiates, benzodiazepines, alcohol, or other sedative-hypnotics.

Where it is running

• Kansas City VA Medical Center — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.